|
Variables
|
TB treatment outcomea
|
cOR (95% CI)
|
P value
|
aOR (95% CI)
|
P value
|
|---|
|
Unsuccessful n (%)
|
Successful n (%)
|
|---|
|
Sex
|
Male
|
45 (5.7)
|
344 (94.3)
|
1
| |
1
| |
|
Female
|
29 (8.1)
|
328 (91.9)
|
1.5(0.92.4)
|
0.12
|
1.5(0.9–2.5)
|
0.10
|
|
Age group (in years)
|
0–14
|
8 (11.6)
|
61(88.4)
|
1
| |
1
| |
|
15–24
|
17 (7.2)
|
220(92.)
|
1.7(0.7–4)
|
0.24
|
1.8(0.73–4.46)
|
0.20
|
|
25–34
|
11 (6.4)
|
160(93.)
|
1.9(0.7–5)
|
0.19
|
2(0.77–5.4)
|
0.15
|
|
35–44
|
18 (16.5)
|
91 (83.5)
|
0.66(0.27–1.6)
|
0.37
|
0.73(0.29–1.8)
|
0.50
|
|
45–54
|
7 (9.2)
|
60 (90.8)
|
1.12(0.38–3.3)
|
0.8
|
1.18(0.4–3.5)
|
0.76
|
|
55–64
|
6 (8.3)
|
36 (91.7)
|
0.78(0.25–2.45)
|
0.68
|
0.8(0.25–2.5)
|
0.70
|
|
≥ 65
|
7 (13.7)
|
44 (86.3)
|
0.8(0.28–2.4)
|
0.72
|
0.86(0.3–2.6)
|
0.78
|
|
Type of TB
|
PTB+
|
18 (9.5)
|
171(90.5)
|
1
| |
1
| |
|
PTB-
|
29 (10.5)
|
247(89.5)
|
0.89(0.48–1.66)
|
0.70
|
1.04(0.5–2)
|
0.89
|
|
EPTB
|
27 (9.6)
|
254(90.4)
|
0.99(0.5–1.8)
|
0.98
|
1.04(0.5–2)
|
0.89
|
|
TB registration status
|
New
|
62 (10.1)
|
550(89.9)
|
1
| |
1
| |
|
Relapse
|
4 (8.2)
|
45 (91.8)
|
1.3(0.44–3.6)
|
0.66
|
1.48(0.5–4.4)
|
0.47
|
|
Treatment after Failure
|
1(5.9)
|
16 (94.1)
|
1.8(0.23–31.8)
|
0.57
|
1.6(0.2–12.7)
|
0.65
|
|
Transfer in
|
6 (9.7)
|
56 (90.3)
|
1.05(0.44–2.5)
|
0.9
|
0.93(0.37–3)
|
0.87
|
|
Other
|
1 (16.7)
|
5 (83.3)
|
0.56(0.06–4.9)
|
0.6
|
0.37(0.04–3.3)
|
0.37
|
|
HIV status
|
Positive
|
21 (11.9)
|
155(88.1)
|
1
| |
1
| |
|
Negative
|
50 (9.2)
|
494(90.8)
|
1.33(0.78–2.3)
|
0.30
|
1.37(0.76–2.4)
|
0.23
|
|
Unknon
|
3 (11.5)
|
23 (88.5)
|
1.03(0.28–3.76)
|
0.95
|
1.13(0.3–4.2)
|
0.5
|
- aNB: the calculation excluded transferred out (n = 219) and treatment outcome unknown (20) cases
